What does this research mean for the field?

Obstructive sleep apnoea is closely linked to the pathophysiology of the metabolic syndrome and predisposes to cardiovascular disease, whereas treatment of sleep apnoea may confer long-term cardiovascular benefits. Novelty: ClaimNovelty.CONFIRMATORY. Consensus alignment: ConsensusAlignment.NEUTRAL.

April 23, 2004European Heart JournalOpen Access

Obstructive sleep apnoea, metabolic syndrome, and cardiovascular outcomes

View Full Paper

Ask AI

Bookmark

Design

Editorial

Authors

AGApoor S. GamiElectrophysiology

Discussion

Member takes

Implication

This editorial emphasizes the pathophysiological links between obstructive sleep apnea, metabolic syndrome, and cardiovascular disease, advocating for rigorous trials to evaluate OSA therapy for cardiovascular risk reduction.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Apoor S. Gami (2004) studied this question.

synapsesocial.com/papers/6a7536fc80fadadbba094c3c https://doi.org/10.1016/j.ehj.2004.03.008

Topics

Coronary artery disease

View Full Paper

Ask AI

Bookmark

Obstructive sleep apnoea, metabolic syndrome, and cardiovascular outcomes

Discussion

Member takes

Implication

Key Points

Cite This Study

Topics

Obstructive sleep apnoea, metabolic syndrome, and cardiovascular outcomes

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Topics

Also Consider